Skip to content

CONDIS MEDICAL: what changed

BE 0728.469.109NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€5,545
2024 · -€28,220+€22,675
Equity
€26,690
2024 · €32,235-€5,545
Cash
€1,639
2024 · €7,289-€5,649
Balance sheet total
€31,193
2024 · €49,378-€18,185

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€17,005

    down €17,005 (-56.5%), from €30,120 to €13,116

    of which Other amounts receivable: -€16,573

  • Cash -€5,649

    down €5,649 (-77.5%), from €7,289 to €1,639

    mainly Investment in fixed assets (net) (-€7,929) and Tax, wage and social debts (-€6,951)

  • Tangible fixed assets +€5,181

    up €5,181 (+50.1%), from €10,349 to €15,530

    of which Plant, machinery and equipment: +€3,153

  • Deferred charges and accrued income -€712

    down €712 (-43.9%), from €1,620 to €908

Equity and liabilities
  • Tax, wage and social debts -€6,951

    down €6,951 (-96.1%), from €7,232 to €280

  • Trade debts -€5,689

    down €5,689 (-57.4%), from €9,911 to €4,222

  • Profit (loss) carried forward -€5,545

    down €5,545 (-20.4%), from €27,235 to €21,690

Income statement
  • Gross operating margin +€24,094

    up €24,094 (+95.0%), from -€25,362 to -€1,269

  • Depreciation +€1,374

    up €1,374 (+100%), from €1,374 to €2,748

  • Taxes +€255

    up €255 (+987%), from €26 to €280

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€28,220
Gross operating margin +€24,094
Depreciation -€1,374
Other operating charges -€6
Financial income +€0
Financial charges +€216
Taxes -€255
Result 2025 -€5,545
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€2,280
Investment -€7,929
Financing €0
Cash 2024 €7,289
Net result for the year -€5,545
Depreciation +€2,748
Receivables within one year +€17,005
Deferred charges and accrued income +€712
Trade debts -€5,689
Tax, wage and social debts -€6,951
Investment in fixed assets (net) -€7,929
Cash 2025 €1,639
brings cash intakes cash out
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €49,378 €31,193 -€18,185 -36.8%
Fixed assets 21/28 €10,349 €15,530 +€5,181 +50.1%
Tangible fixed assets 22/27 €10,349 €15,530 +€5,181 +50.1%
Plant, machinery and equipment 23 €1,637 €4,790 +€3,153 +193%
Furniture and vehicles 24 €8,711 €10,739 +€2,028 +23.3%
Current assets 29/58 €39,029 €15,663 -€23,366 -59.9%
Amounts receivable within one year 40/41 €30,120 €13,116 -€17,005 -56.5%
Trade receivables 40 €8,446 €8,015 -€431 -5.1%
Other amounts receivable 41 €21,674 €5,101 -€16,573 -76.5%
Cash at bank and in hand 54/58 €7,289 €1,639 -€5,649 -77.5%
Deferred charges and accrued income 490/1 €1,620 €908 -€712 -43.9%
Total equity and liabilities 10/49 €49,378 €31,193 -€18,185 -36.8%
Equity 10/15 €32,235 €26,690 -€5,545 -17.2%
Contributions 10/11 €5,000 €5,000 = 0.0%
Profit (loss) carried forward 14 €27,235 €21,690 -€5,545 -20.4%
Amounts payable 17/49 €17,143 €4,503 -€12,640 -73.7%
Amounts payable within one year 42/48 €17,143 €4,503 -€12,640 -73.7%
Trade debts 44 €9,911 €4,222 -€5,689 -57.4%
Suppliers 440/4 €9,911 €4,222 -€5,689 -57.4%
Taxes, remuneration and social security 45 €7,232 €280 -€6,951 -96.1%
Taxes 450/3 €7,232 €280 -€6,951 -96.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,374 €2,748 +€1,374 +100%
Other operating charges 640/8 €1,024 €1,030 +€6 +0.6%
Gross operating margin 9900 -€25,362 -€1,269 +€24,094 +95.0%
Operating profit (loss) 9901 -€27,760 -€5,047 +€22,713 +81.8%
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €434 €217 -€216 -49.9%
Recurring financial charges 65 €434 €217 -€216 -49.9%
Profit (loss) for the period before taxes 9903 -€28,194 -€5,265 +€22,929 +81.3%
Income taxes 67/77 €26 €280 +€255 +987%
Profit (loss) for the period 9904 -€28,220 -€5,545 +€22,675 +80.4%
Profit (loss) for the period to be appropriated 9905 -€28,220 -€5,545 +€22,675 +80.4%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€26,690 to €26,690

Midpoint €26,690 · adjusted equity only

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €26,690
Indication €26,690

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€26,690
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€26,690

Capitalised earnings

net result for the year (9904)
2025
-€5,545
2024
-€28,220
2023
€20,297
2022
€11,715
2021
€21,931
Average result
-€4,489
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.